| Literature DB >> 29248481 |
Paola de Candia1, Giuseppe Matarese2.
Abstract
Life expectancy has considerably increased over the last decades. The negative consequence of this augmented longevity has been a dramatic increase of age-related chronic neurodegenerative diseases, such as Alzheimer's, Parkinson's and multiple sclerosis. Epidemiology is telling us there exists a strong correlation between the neuronal loss characterizing these disorders and metabolic dysfunction. This review aims at presenting the evidence supporting the existence of a molecular system linking metabolism with neurodegeneration, with a specific focus on the role of two hormones with a key role in the regulatory cross talk between metabolic imbalance and the damage of nervous system: leptin and ghrelin. This article is part of the Special Issue entitled 'Metabolic Impairment as Risk Factors for Neurodegenerative Disorders.'Entities:
Keywords: Ghrelin; Leptin; Metabolism; Neurodegeneration; Neuroinflammation
Mesh:
Substances:
Year: 2017 PMID: 29248481 DOI: 10.1016/j.neuropharm.2017.12.025
Source DB: PubMed Journal: Neuropharmacology ISSN: 0028-3908 Impact factor: 5.250